BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16955785)

  • 1. Severe chemotherapy-induced parosmia.
    Müller A; Landis BN; Platzbecker U; Holthoff V; Frasnelli J; Hummel T
    Am J Rhinol; 2006; 20(4):485-6. PubMed ID: 16955785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euosmia: a rare form of parosmia.
    Landis BN; Frasnelli J; Hummel T
    Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distorted odorant perception: analysis of a series of 56 patients with parosmia.
    Bonfils P; Avan P; Faulcon P; Malinvaud D
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):107-12. PubMed ID: 15723940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    medRxiv; 2022 Nov; ():. PubMed ID: 35350197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma.
    Lötsch J; Ultsch A; Eckhardt M; Huart C; Rombaux P; Hummel T
    Neuroimage Clin; 2016; 11():99-105. PubMed ID: 26937377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection.
    Shiga H; Okuda K; Taki J; Watanabe N; Tonami H; Kinuya S; Miwa T
    Int Forum Allergy Rhinol; 2019 Nov; 9(11):1252-1256. PubMed ID: 31356735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
    Hernandez AK; Landis BN; Altundag A; Fjaeldstad AW; Gane S; Holbrook EH; Huart C; Konstantinidis I; Lechner M; Macchi A; Portillo Mazal P; Miwa T; Philpott CM; Pinto JM; Poletti SC; Vodicka J; Welge-Luessen A; Whitcroft KL; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):312-320. PubMed ID: 37062268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of olfactory dysfunction.
    Hummel T; Lötsch J
    Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):347-51. PubMed ID: 20403850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features in Russian Patients with COVID-Associated Parosmia/Phanthosmia.
    Kopishinskaia S; Lapshova D; Sherman M; Velichko I; Voznesensky N; Voznesenskaia V
    Psychiatr Danub; 2021 Sep; 33(Suppl 9):130-136. PubMed ID: 34559791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosmia after intranasal zinc gluconate use.
    Jafek BW; Linschoten MR; Murrow BW
    Am J Rhinol; 2004; 18(3):137-41. PubMed ID: 15283486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.